IGF1 can reduce blood glucose levels and has been used to treat patients with type 1 and 2 diabetes This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
It is widely referenced in research environments for its role in signalling pathway studies and is commonly examined in relation to cellular response models
There is no established clinical timeline, because the controlled trials that would establish one have not been done
primary care-based study. Med Glas (Zenica) 10.2 (2013): 203-210
Vitamin B12 is important for the health of your nervous system and your red blood cells
If BPC-157 was purchased today, the patent would likely expire in 2033 before the phase 1-2-3 trials would be completed, at which point all the generic manufacturers would be able to push the product on the back of all the hard work a pharmaceutical company can do (Im not sure if FDA approval would push the expiration of the patent back, but even then it would not be so financial lucrative)
